Kangstem Biotech

KOR | ENG

주메뉴

Company
- Company
  
  Kangstem Biotech is
  engaged in various fields
  of bio-innovation.
- About Us
- Kangstem Biotech
- Global R&D Center
- Stem Cell GMP Center
- Welcome Message
- Vision & Mission
- History
- Location
Business
- Business
  
  Kangstem Biotech is
  engaged in various fields
  of bio-innovation.
- Stem Cell Therapy
- FURESTEM-OA Kit Inj.
- FURESTEM-AD® Inj.
- FURESTEM-RA® Inj.
- Advanced Regenerative Medicine
- Organoid
- Organoid
- Skin Organoid
- Islet Organoid
- CDMO Business
- CDMO
- JUVENTAS
- Stem Cell Culture Business
- Health&Beauty Business
R & D
- R & D
  
  Kangstem Biotech is
  engaged in various fields
  of bio-innovation.
- Core Technology
- Umbilical Cord Blood Stem Cell
- High-Compact Technology Strategy
- R&D Achievements
Investors
- Investors
  
  Kangstem Biotech is
  engaged in various fields
  of bio-innovation.
- Notice
- PR
- Press Release
- PR Resource Center

Core Technology

R&D Achievements

Kangstem Biotech is advancing innovative therapies through its cell therapy and organoid platforms, with a strong foundation in scientific evidence and clinical potential.

R&D Achievements

2018.09

Intravenous Infusion of Umbilical Cord Blood-Derived Mesenchymal Stem Cells in Rheumatoid Arthritis: A Phase Ia Clinical Trial

Journal : Stem Cells Translational Medicine

2017.11

Exosomes derived from human umbilical cord blood mesenchymal stem cells stimulates rejuvenation of human skin

Journal : BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

2017.08

Generation of patient specific human neural stem cells from Niemann-Pick disease type C patient-derived fibroblasts

Journal : Oncotarget

2017.02

Reprogramming Enhancers in Somatic Cell Nuclear Transfer, iPSC Technology, and Direct Conversion

Journal : Stem Cell Reviews and Reports

2017.01

Clinical Trial of Human Umbilical Cord Blood-derived Stem Cells for the Treatment of Moderate-to-Severe Atopic Dermatitis: Phase I/IIa Studies

Journal : STEM CELLS

2016.12

Human umbilical cord blood-stem cells direct macrophage polarization and block inflammasome activation to alleviate rheumatoid arthritis

Journal : Cell Death & Disease

2016.10

Human umbilical cord blood-derived mesenchymal stem cells ameliorate psoriasis-like skin inflammation in mice.

Journal : Biochemistry and Biophysics Reports

2015.12

Mica Nanoparticle, STB-HO Eliminates the Human Breast Carcinoma Cells by Regulating the Interaction of Tumor with its Immune Microenvironment

Journal : Scientific Reports

2015.04

Human umbilical cord blood mesenchymal stem cell-derived PGE2 and TGF-β1 alleviate atopic dermatitis by reducing mast cell degranulation

Journal : STEM CELLS

2015.01

Rapid and Efficient Direct Conversion of Human Adult Somatic Cells into Neural Stem Cells by HMGA2/let-7b

Journal : Cell Reports

1 2 3 4

Company

About Us

Business

Stem Cell Therapy

Organoid

CDMO Business

Health&Beauty Business

R&D

Core Technology

Investors

Notice